(Q46821578)

25 December 2017

title

Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease (English)

1 reference

25 December 2017

inflammatory bowel diseases

main subject

inflammation

0 references

1 reference

Hiroyuki Hanai

1

1 reference

25 December 2017

Takayuki Iida

2

1 reference

25 December 2017

Ken Takeuchi

3

1 reference

25 December 2017

Fumitoshi Watanabe

4

1 reference

25 December 2017

Masami Yamada

5

1 reference

25 December 2017

Masataka Kikuyama

6

1 reference

25 December 2017

Yasushi Maruyama

7

1 reference

25 December 2017

Yasushi Iwaoka

8

1 reference

25 December 2017

Kazuhisa Hirayama

9

1 reference

25 December 2017

Seiji Nagata

10

1 reference

25 December 2017

Kenji Takai

11

1 reference

25 December 2017

language of work or name

English

0 references

publication date

2 January 2008

1 reference

25 December 2017

The American Journal of Gastroenterology

published in

1 reference

25 December 2017

volume

103

1 reference

25 December 2017

page(s)

1210-1216

1 reference

25 December 2017

issue

5

1 reference

25 December 2017

The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

The CD14+ CD16+ blood monocytes: their role in infection and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

Blood monocytes consist of two principal subsets with distinct migratory properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

CD14++ monocytes, CD14+/CD16+ subset and soluble CD14 as biological markers of inflammatory systemic diseases and monitoring immunosuppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

The key role of macrophages in the immunopathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence of in vivo activation in active disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

Role of cytokines in the pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

The production of cytokines by polymorphonuclear neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

The logics of leukocytapheresis as a natural biological therapy for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naïve patients with active ulcerative colitis: a prospective uncontrolled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

Inflammatory bowel disease: etiology and pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

Medical therapy for ulcerative colitis 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

On-line hemodiafiltration reduces the proinflammatory CD14+CD16+ monocyte-derived dendritic cells: A prospective, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

Selective depletion of CD14+ CD16+ monocytes by glucocorticoid therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

Mechanism of glucocorticoid-induced depletion of human CD14+CD16+ monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

Therapeutic leukocytapheresis for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

Human neutrophil Fc receptor-mediated adhesion under flow: a hollow fibre model of intravascular arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

Fcgamma and complement receptors: expression, role and co-operation in mediating the oxidative burst and degranulation of neutrophils of Brazilian systemic lupus erythematosus patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

Ig-binding receptors on human NK cells as effector and regulatory surface molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01714.X

10.1111/J.1572-0241.2007.01714.X

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

18177452

1 reference

25 December 2017